Riociguat: Mode of action and clinical development in pulmonary hypertension
about
Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension.Phosphodiesterase type 5 inhibitor to riociguat transition is associated with hemodynamic and symptomatic improvement in pulmonary hypertensionThin Air Resulting in High Pressure: Mountain Sickness and Hypoxia-Induced Pulmonary Hypertension.Update on novel targets and potential treatment avenues in pulmonary hypertension.First-in-child use of the oral soluble guanylate cyclase stimulator riociguat in pulmonary arterial hypertension.Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat.An update on new and emerging therapies for cystic fibrosis.Meeting report of the 8th International Conference on cGMP "cGMP: generators, effectors, and therapeutic implications" at Bamberg, Germany, from June 23 to 25, 2017.Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding.Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH.
P2860
Q33596457-58BF3694-DCAC-415C-8E22-FC6CA714B326Q33788560-BD05FB60-C62D-4525-96A8-D596DD13BF1DQ39316798-1A4CE40F-FADF-4A15-8F91-47F93B212AA5Q42784219-C52A2179-7A87-47D0-AB95-021942A6B379Q47110570-BB652D92-20C7-425C-88CC-3EA852093191Q47584698-4A2F4415-AAB3-426F-9F28-458E73F51B70Q47652015-7BE48F86-80F0-4008-980F-3AA02A326715Q47904506-12B8121B-A0AC-4D0F-98DC-559CAFD2D976Q52670776-E77C1D39-1F06-4DD0-8BF7-558BB8885AE3Q55193715-B5E752E1-8F25-417F-A0D5-53088486E01A
P2860
Riociguat: Mode of action and clinical development in pulmonary hypertension
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Riociguat: Mode of action and clinical development in pulmonary hypertension
@ast
Riociguat: Mode of action and clinical development in pulmonary hypertension
@en
Riociguat: Mode of action and clinical development in pulmonary hypertension
@nl
type
label
Riociguat: Mode of action and clinical development in pulmonary hypertension
@ast
Riociguat: Mode of action and clinical development in pulmonary hypertension
@en
Riociguat: Mode of action and clinical development in pulmonary hypertension
@nl
prefLabel
Riociguat: Mode of action and clinical development in pulmonary hypertension
@ast
Riociguat: Mode of action and clinical development in pulmonary hypertension
@en
Riociguat: Mode of action and clinical development in pulmonary hypertension
@nl
P2093
P50
P1433
P1476
Riociguat: Mode of Action and Clinical Development in Pulmonary Hypertension
@en
P2093
David Langleben
James R Klinger
Johannes-Peter Stasch
Martin R Wilkins
P304
P356
10.1016/J.CHEST.2016.05.024
P407
P577
2016-06-02T00:00:00Z